Multi-Modal Graph Neural Network with Transformer-Guided Adaptive Diffusion for Preclinical Alzheimer Classification
2026-06-02 • Machine Learning
Machine LearningArtificial Intelligence
AI summaryⓘ
The authors developed a new method to analyze brain networks to better detect early signs of Alzheimer’s disease. They improved on existing tools by combining different ways to gather information from both nearby and distant brain regions. Their model also highlights important brain areas linked to early disease stages. This approach helps improve early diagnosis using multiple types of brain data.
Graph Neural NetworksBrain NetworksAlzheimer's DiseaseDiffusion ProcessTransformerMulti-head AttentionRegions of Interest (ROIs)Multimodal DataNeurodegenerative Disease
Authors
Jaeyoon Sim, Minjae Lee, Guorong Wu, Won Hwa Kim
Abstract
The graphical representation of the brain offers critical insights into diagnosing and prognosing neurodegenerative disease via relationships between regions of interest (ROIs). Despite recent emergence of various Graph Neural Networks (GNNs) to effectively capture the relational information, there remain inherent limitations in interpreting the brain networks. Specifically, convolutional approaches ineffectively aggregate information from distant neighborhoods, while attention-based methods exhibit deficiencies in capturing node-centric information, particularly in retaining critical characteristics from pivotal nodes. These shortcomings reveal challenges for identifying disease-specific variation from diverse features from different modalities. In this regard, we propose an integrated framework guiding diffusion process at each node by a downstream transformer where both short- and long-range properties of graphs are aggregated via diffusion-kernel and multi-head attention respectively. We demonstrate the superiority of our model by improving performance of pre-clinical Alzheimer's disease (AD) classification with various modalities. Also, our model adeptly identifies key ROIs that are closely associated with the preclinical stages of AD, marking a significant potential for early diagnosis and prevision of the disease.